<DOC>
	<DOC>NCT00073203</DOC>
	<brief_summary>The purpose of this research study is to determine the effectiveness of 2 target doses of R228060 in comparison with placebo during 6 weeks of treatment in moderately to severely depressed adult subjects with major depressive disorder. Approximately 488 subjects will be involved in the study.</brief_summary>
	<brief_title>A 6 Week Study to Determine the Effectiveness of R228060 in Adult Subjects With Major Depressive Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder, Major</mesh_term>
	<mesh_term>Paroxetine</mesh_term>
	<criteria>Generally healthy adults on the basis of a physical examination, medical history, ECG and laboratory workup. Subject needs to meet criteria for diagnosis of moderate or severe major depression as defined by the protocol. The subject also needs to be an outpatient to participate in this study.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2004</verification_date>
</DOC>